SI-BONE Inc (SIBN)

• Market cap: $612M
• 1 day: 0.14%
• 5 days: 5.11%
• 1 month: -1.84%
• 3 months: -9.82%
• 6 months: 13.73%
• Year to date: 3.45%
• 1 year: 0.98%
• 5 years: -7.63%
• 10 years: -28.17%
• Sector: Healthcare
• Industry: Medical Devices

About: SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Employees: 349

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

76% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 17

21% more call options, than puts

Call options by funds: $4.29M | Put options by funds: $3.55M

18% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 44

8% more funds holding

Funds holding: 133 [Q3] → 143 (+10) [Q4]

2% less capital invested

Capital invested by funds: $569M [Q3] → $558M (-$10.9M) [Q4]

2.74% less ownership

Funds ownership: 97.65% [Q3] → 94.91% (-2.74%) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $22 53% upside
• Avg. target: $26 79% upside
• High target: $32 122% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Citizens Capital Markets David Turkaly 26% 1-year accuracy 7 / 27 met price target	122% upside $32	Market Outperform Reiterated	25 Feb 2025
Truist Securities Samuel Brodovsky 25% 1-year accuracy 2 / 8 met price target	53% upside $22	Buy Reiterated	25 Feb 2025
Cantor Fitzgerald Ross Osborn 24% 1-year accuracy 11 / 45 met price target	73% upside $25	Overweight Reiterated	25 Feb 2025
Needham David Saxon 35% 1-year accuracy 23 / 65 met price target	67% upside $24	Buy Maintained	25 Feb 2025